Dysfunctional hematopoiesis that results in anemia, thrombocytopenia, and decreased lymphocytes as shown above in active MEK+ mice at the terminal stage is characteristic of MDS [4], [32]. This evidence concerns the gene MAP2K7 and Thrombocytopenia.